Dear OncoLink "Ask The Experts,"
What does biochemical failure mean?
Richard Whittington, MD, Associate Professor of Radiation Oncology at the University of Pennsylvania School of Medicine, responds:
Biochemical failure is the return of a previously treated prostate cancer, which is determined by a rising PSA (prostate specific antigen). This differs from clinical failure, which is detected by a radiology scan (such as CAT scan or bone scan) or tissue biopsy.
There is no standard definition of biochemical failure. Some people say biochemical failure is defined as 3 consecutive rises in PSA, while others say it is defined as 2.0 ng above the lowest post-treatment measurement. Still some others will qualify their answer by saying 3 rises with a minimum total rise of 1.0ng/ml. Even after radical prostatectomy, and knowing that the only thing in the body that makes PSA is the normal prostate gland or prostate cancer, some people still say that a PSA of 0.1 is a recurrence, while others use 0.2 or 0.4 (2 rises above “undetectable”).
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2016 Trustees of The University of Pennsylvania